COVID-19 dual-antibody therapies effective against variants in animal study

(Washington University School of Medicine) A study from Washington University School of Medicine in St. Louis suggests that many, but not all, COVID-19 therapies made from combinations of two antibodies are effective against a wide range of virus variants. Further, combination therapies appear to prevent the emergence of drug resistance.